Market Place
Sourcing Support
Matica Biotechnology Establishes CDMO Partnership with KaliVir
24 Oct 2024 //
BUSINESSWIRE
KaliVir Doses First Patient In VET3-TGI Phase 1/1b Trial
08 Oct 2024 //
BUSINESSWIRE
KaliVir Immunotherapeutics Appoints Schond Greenway as Chief Financial Officer
04 Sep 2024 //
BUSINESSWIRE
KaliVir`s VET3-TGI Gets FDA IND Clearance For Solid Tumors
01 Jul 2024 //
BUSINESSWIRE
KaliVir Immunotherapeutics Appoints James M. Burke as Chief Medical Officer
21 Feb 2024 //
BUSINESSWIRE
KaliVir Announces Opening of GMP Cleanroom Facility
31 Jan 2024 //
BUSINESSWIRE
KaliVir Immunotherapeutics Announces FDA Clearance of IND for ASP1012
24 Oct 2023 //
BUSINESSWIRE
KaliVir Immunotherapeutics Announces New In Vivo Data Potent Therapeutic
17 Apr 2023 //
PR NEWSWIRE
KaliVir Immunotherapeutics Establishes Clinical and Scientific Advisory Boards
13 Dec 2022 //
PRNEWSWIRE
KaliVir Appoints Adina Pelusio as SVP of Clinical Operations to Clinical DeVP
01 Nov 2022 //
BIOSPACE
SIGA Announces Oncology Collaboration with KaliVir Immunotherapeutics
15 Jul 2022 //
GLOBENEWSWIRE
KaliVir Enters into Global Exclusive Licensing Agreement with Roche
23 May 2022 //
PRNEWSWIRE
KaliVir Immunotherapeutics Appoints Drs. Terry Hermiston
17 Jun 2021 //
PRNEWSWIRE
KaliVir Appoints Drs. Terry Hermiston and Jon Wigginton to Board of Directors
17 Jun 2021 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.